DMKPQ (DMK Pharmaceuticals) OCF Yield %: 524,100.00 (As of Jun. 27, 2026)


DMKPQ DMK Pharmaceuticals Corp DMKPQ
16 GF Score
Price $0.00
View Full Analysis

What is DMK Pharmaceuticals OCF Yield %?

DMK Pharmaceuticals DMKPQ -99.00% 16 OCF Yield % is 524,100.00 as of Jun. 27, 2026. GuruFocus rates DMKPQ with a GF Score™ of 16/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, DMK Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-9.38 Mil, and Market Cap is $0.00 Mil. Therefore, DMK Pharmaceuticals's OCF Yield % for today is 524,100.00%.

The historical rank and industry rank for DMK Pharmaceuticals's OCF Yield % or its related term are showing as below:

DMKPQ' s OCF Yield % Range Over the Past 10 Years
Min: -9814000   Med: 0   Max: 524100
Current: 524100


During the past 13 years, the highest OCF Yield % of DMK Pharmaceuticals was 524100.00%. The lowest was -9814000.00%. And the median was %.

DMKPQ's OCF Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.61 vs DMKPQ: 524100.00

DMK Pharmaceuticals's OCF Margin % for the quarter that ended in Sep. 2023 was %.


DMK Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


DMK Pharmaceuticals OCF Yield % Related Terms


DMK Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for DMK Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMK Pharmaceuticals OCF Yield % Chart

DMK Pharmaceuticals Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.67 -45.93 -45.90 -41.75 -101.99

DMK Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.72 -23.97 -32.10 -152.83 -214.91

DMKPQ vs CNNC, THCT, VFRM: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DMK Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DMK Pharmaceuticals OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DMK Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where DMK Pharmaceuticals's OCF Yield % falls into.


DMKPQ
16GF Score
DMK Pharmaceuticals Corp DMKPQ
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DMK Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

DMK Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-25.901 / 25.396690857
=-101.99%

DMK Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Sep. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-3.737 * 4 / 6.955455
=-214.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 524,100.00 mean?
DMK Pharmaceuticals (DMKPQ) has a OCF Yield % of 524,100.00 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DMK Pharmaceuticals and its competitors.
Is DMK Pharmaceuticals' OCF Yield % too high?
DMK Pharmaceuticals' current OCF Yield % is 524,100.00. The Drug Manufacturers industry median OCF Yield % is 3.61. DMK Pharmaceuticals' value of 524,100.00 is 14517905.5% above this industry median. Overall, DMK Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does DMK Pharmaceuticals' OCF Yield % compare to CNNC and THCT?
DMK Pharmaceuticals' OCF Yield % of 524,100.00 can be compared against companies in the Drug Manufacturers industry. The industry median OCF Yield % is 3.61. DMK Pharmaceuticals' value of 524,100.00 is 14517905.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DMK Pharmaceuticals's current OCF Yield % of 524,100.00 is 14517905.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on DMK Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DMK Pharmaceuticals's current OCF Yield % is 524,100.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DMK Pharmaceuticals stock overvalued right now?
DMK Pharmaceuticals (DMKPQ) has a current OCF Yield % of 524,100.00. The current OCF Yield % is 524,100.00 and 14517905.5% above the Drug Manufacturers industry median of 3.61. DMK Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For DMK Pharmaceuticals (DMKPQ), the current OCF Yield % is 524,100.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DMK Pharmaceuticals Business Description

Address 11682 El Camino Real, Suite 300, San Diego, CA, USA, 92130
DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
16GF Score

Get the complete analysis for DMKPQ

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price